These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 30025902

  • 1. New lead elements for histamine H3 receptor ligands in the pyrrolo[2,3-d]pyrimidine class.
    Espinosa-Bustos C, Frank A, Arancibia-Opazo S, Salas CO, Fierro A, Stark H.
    Bioorg Med Chem Lett; 2018 Sep 15; 28(17):2890-2893. PubMed ID: 30025902
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and biological activity of novel tert-butyl and tert-pentylphenoxyalkyl piperazine derivatives as histamine H3R ligands.
    Szczepańska K, Karcz T, Mogilski S, Siwek A, Kuder KJ, Latacz G, Kubacka M, Hagenow S, Lubelska A, Olejarz A, Kotańska M, Sadek B, Stark H, Kieć-Kononowicz K.
    Eur J Med Chem; 2018 May 25; 152():223-234. PubMed ID: 29723785
    [Abstract] [Full Text] [Related]

  • 3. Nature-inspired pyrrolo[2,3-d]pyrimidines targeting the histamine H3 receptor.
    Frank A, Meza-Arriagada F, Salas CO, Espinosa-Bustos C, Stark H.
    Bioorg Med Chem; 2019 Jul 15; 27(14):3194-3200. PubMed ID: 31176569
    [Abstract] [Full Text] [Related]

  • 4. Structural modifications in the distal, regulatory region of histamine H3 receptor antagonists leading to the identification of a potent anti-obesity agent.
    Szczepańska K, Pockes S, Podlewska S, Höring C, Mika K, Latacz G, Bednarski M, Siwek A, Karcz T, Nagl M, Bresinsky M, Mönnich D, Seibel U, Kuder KJ, Kotańska M, Stark H, Elz S, Kieć-Kononowicz K.
    Eur J Med Chem; 2021 Mar 05; 213():113041. PubMed ID: 33261900
    [Abstract] [Full Text] [Related]

  • 5. Studies on molecular properties prediction and histamine H3 receptor affinities of novel ligands with uracil-based motifs.
    Lipani L, Odadzic D, Weizel L, Schwed JS, Sadek B, Stark H.
    Eur J Med Chem; 2014 Oct 30; 86():578-88. PubMed ID: 25218907
    [Abstract] [Full Text] [Related]

  • 6. Optimization and preclinical evaluation of novel histamine H3receptor ligands: Acetyl and propionyl phenoxyalkyl piperazine derivatives.
    Szczepańska K, Karcz T, Kotańska M, Siwek A, Kuder KJ, Latacz G, Mogilski S, Hagenow S, Lubelska A, Sobolewski M, Stark H, Kieć-Kononowicz K.
    Bioorg Med Chem; 2018 Dec 15; 26(23-24):6056-6066. PubMed ID: 30448256
    [Abstract] [Full Text] [Related]

  • 7. Discovery of novel lead in the group of N-substituted piperazine ether derivatives with potential histamine H3 receptor activity.
    Kuder KJ, Stachnik M, Schunack W, Szymańska E, Kieć-Kononowicz K.
    Med Chem; 2014 Dec 15; 10(6):588-99. PubMed ID: 24047214
    [Abstract] [Full Text] [Related]

  • 8. Non-Imidazole Histamine H3 Ligands. Part VI. Synthesis and Preliminary Pharmacological Investigation of Thiazole-Type Histamine H3-Receptor Antagonists with Lacking a Nitrogen Nucleus in the Side Chain.
    Guryn R, Staszewski M, Kopczacki P, Walczyski K.
    Med Chem; 2016 Dec 15; 13(1):65-76. PubMed ID: 27220560
    [Abstract] [Full Text] [Related]

  • 9. Search for new multi-target compounds against Alzheimer's disease among histamine H3 receptor ligands.
    Bajda M, Łażewska D, Godyń J, Zaręba P, Kuder K, Hagenow S, Łątka K, Stawarska E, Stark H, Kieć-Kononowicz K, Malawska B.
    Eur J Med Chem; 2020 Jan 01; 185():111785. PubMed ID: 31669851
    [Abstract] [Full Text] [Related]

  • 10. Non-imidazole histamine H3 receptor ligands incorporating antiepileptic moieties.
    Sadek B, Schwed JS, Subramanian D, Weizel L, Walter M, Adem A, Stark H.
    Eur J Med Chem; 2014 Apr 22; 77():269-79. PubMed ID: 24650714
    [Abstract] [Full Text] [Related]

  • 11. Discovery of novel steroidal histamine H3 receptor antagonists/inverse agonists.
    Ledneczki I, Tapolcsányi P, Gábor E, Éles J, Greiner I, Schmidt É, Némethy Z, Kedves RS, Balázs O, Román V, Lévay G, Mahó S.
    Bioorg Med Chem Lett; 2017 Oct 01; 27(19):4525-4530. PubMed ID: 28888822
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and evaluation of novel ligands for the histamine H₄ receptor based on a pyrrolo[2,3-d]pyrimidine scaffold.
    Gao LJ, Schwed JS, Weizel L, De Jonghe S, Stark H, Herdewijn P.
    Bioorg Med Chem Lett; 2013 Jan 01; 23(1):132-7. PubMed ID: 23218604
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and biological activity of novel tert-amylphenoxyalkyl (homo)piperidine derivatives as histamine H3R ligands.
    Kuder KJ, Łażewska D, Kaleta M, Latacz G, Kottke T, Olejarz A, Karcz T, Fruziński A, Szczepańska K, Karolak-Wojciechowska J, Stark H, Kieć-Kononowicz K.
    Bioorg Med Chem; 2017 May 15; 25(10):2701-2712. PubMed ID: 28372935
    [Abstract] [Full Text] [Related]

  • 14. Structural and Molecular Insight into Piperazine and Piperidine Derivatives as Histamine H3 and Sigma-1 Receptor Antagonists with Promising Antinociceptive Properties.
    Szczepańska K, Podlewska S, Dichiara M, Gentile D, Patamia V, Rosier N, Mönnich D, Ruiz Cantero MC, Karcz T, Łażewska D, Siwek A, Pockes S, Cobos EJ, Marrazzo A, Stark H, Rescifina A, Bojarski AJ, Amata E, Kieć-Kononowicz K.
    ACS Chem Neurosci; 2022 Jan 05; 13(1):1-15. PubMed ID: 34908391
    [Abstract] [Full Text] [Related]

  • 15. Drug-likeness approach of 2-aminopyrimidines as histamine H3 receptor ligands.
    Sadek B, Schreeb A, Schwed JS, Weizel L, Stark H.
    Drug Des Devel Ther; 2014 Jan 05; 8():1499-513. PubMed ID: 25278747
    [Abstract] [Full Text] [Related]

  • 16. Novel naphthyloxy derivatives - Potent histamine H3 receptor ligands. Synthesis and pharmacological evaluation.
    Łażewska D, Kaleta M, Hagenow S, Mogilski S, Latacz G, Karcz T, Lubelska A, Honkisz E, Handzlik J, Reiner D, Satała G, Filipek B, Stark H, Kieć-Kononowicz K.
    Bioorg Med Chem; 2018 May 15; 26(9):2573-2585. PubMed ID: 29681486
    [Abstract] [Full Text] [Related]

  • 17. A Versatile Sub-Nanomolar Fluorescent Ligand Enables NanoBRET Binding Studies and Single-Molecule Microscopy at the Histamine H3 Receptor.
    Rosier N, Grätz L, Schihada H, Möller J, Işbilir A, Humphrys LJ, Nagl M, Seibel U, Lohse MJ, Pockes S.
    J Med Chem; 2021 Aug 12; 64(15):11695-11708. PubMed ID: 34309390
    [Abstract] [Full Text] [Related]

  • 18. Histamine H3 receptor antagonists with peptidomimetic (keto)piperazine structures to inhibit Aβ oligomerisation.
    Falkenstein M, Reiner-Link D, Zivkovic A, Gering I, Willbold D, Stark H.
    Bioorg Med Chem; 2021 Nov 15; 50():116462. PubMed ID: 34695709
    [Abstract] [Full Text] [Related]

  • 19. N-Substituted piperazine derivatives as potential multitarget agents acting on histamine H3 receptor and cancer resistance proteins.
    Szczepańska K, Kincses A, Vincze K, Szymańska E, Latacz G, Kuder KJ, Stark H, Spengler G, Handzlik J, Kieć-Kononowicz K.
    Bioorg Med Chem Lett; 2020 Nov 15; 30(22):127522. PubMed ID: 32871268
    [Abstract] [Full Text] [Related]

  • 20. The discovery of quinoline based single-ligand human H1 and H3 receptor antagonists.
    Procopiou PA, Ancliff RA, Gore PM, Hancock AP, Hodgson ST, Holmes DS, Keeling SP, Looker BE, Parr NA, Rowedder JE, Slack RJ.
    Bioorg Med Chem Lett; 2016 Dec 15; 26(24):5855-5859. PubMed ID: 27866818
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.